Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-03-04
1994-08-02
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514291, 514411, 540581, 546 80, 548430, 548431, C07D47118, C07D48718, A61K 3144, A61K 3155
Patent
active
053345916
ABSTRACT:
Conformationally constrained tricyclic thienothiopyran compounds are topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma associated therewith.
REFERENCES:
patent: 4619939 (1985-10-01), Maren
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 5175284 (1992-12-01), Baldwin et al.
Baldwin John J.
Ponticello Gerald S.
Shepard Kenneth L.
Williams Theresa M.
Ayler Sylvia A.
Daniel Mark R.
DiPrima Joseph F.
Merck & Co. , Inc.
Rotman Alan L.
LandOfFree
Tricyclic thienothiopyran carbonic anhydrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic thienothiopyran carbonic anhydrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic thienothiopyran carbonic anhydrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64966